Amanote Research
Register
Sign In
P1.01-107 the Impact of Anlotinib on Quality of Life in Patients With Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.664
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
X. Si
L. Zhang
H. Wang
X. Zhang
M. Wang
B. Han
K. Li
Q. Wang
J. Shi
Z. Wang
Y. Cheng
J. He
Y. Shi
W. Chen
X. Wang
Y. Luo
K. Nan
F. Jin
B. Li
Y. Chen
J. Zhou
D. Wang
Publisher
Elsevier BV